Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

People In Brief

This article was originally published in The Gray Sheet

Executive Summary

Diagnostic exec to take charge at Roche: Roche Diagnostics CEO Severin Schwan will succeed Franz Humer as CEO of Roche next March, the drug and diagnostics giant announced July 19. Humer will remain chairman of the company's board. A new diagnostics chief has yet to be announced. Schwan is leading Roche's $3 billion hostile takeover of Ventana Medical Systems, an acquisition aimed at providing the company with platform technology for tissue-based diagnostic tests to pair with targeted cancer drugs (1"The Gray Sheet" July 2, 2007, p. 10). The exec has also led several other acquisitions in the diagnostics unit during the first half of the year, including the purchase of high-throughput firm 454 Life Sciences, research microarray firm NimbleGen and BioVeris...
Advertisement

Related Content

Advertisement
UsernamePublicRestriction

Register

MT025056

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel